C07H 15/18
Acyclic radicals, substituted by carbocyclic rings
C07H15/18 (Acyclic radicals, substituted by carbocyclic rings) appears on 534 US grants and 485 published applications in this corpus.
Search patents in C07H- Granted patents
- 534
- Published applications
- 485
- Assignees
- 412
- Inventors
- 1,761
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 7 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 9 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 4 | 0 |
| 1985 | 7 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 8 | 0 |
| 1993 | 11 | 0 |
| 1994 | 13 | 0 |
| 1995 | 13 | 0 |
| 1996 | 14 | 0 |
| 1997 | 25 | 0 |
| 1998 | 27 | 0 |
| 1999 | 15 | 0 |
| 2000 | 12 | 0 |
| 2001 | 11 | 3 |
| 2002 | 14 | 11 |
| 2003 | 12 | 14 |
| 2004 | 6 | 10 |
| 2005 | 4 | 9 |
| 2006 | 3 | 10 |
| 2007 | 3 | 8 |
| 2008 | 9 | 10 |
| 2009 | 4 | 14 |
| 2010 | 9 | 14 |
| 2011 | 4 | 11 |
| 2012 | 12 | 28 |
| 2013 | 14 | 18 |
| 2014 | 13 | 34 |
| 2015 | 22 | 33 |
| 2016 | 15 | 23 |
| 2017 | 20 | 20 |
| 2018 | 22 | 17 |
| 2019 | 16 | 19 |
| 2020 | 20 | 30 |
| 2021 | 17 | 19 |
| 2022 | 14 | 25 |
| 2023 | 16 | 31 |
| 2024 | 19 | 23 |
| 2025 | 13 | 37 |
| 2026 | 7 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Triterpene saponin variants, methods of synthesis and use thereof4 Aug 2026US 12,698,304 B2Memorial Sloan Kettering Cancer Center
- Synthetic glycolipids and glycoliposome compositions : suitable for cargo delivery to the central nervous system28 Jul 2026US 12,691,069 B2Koranex Capital
- Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells16 Jun 2026US 12,655,171 B2Deciduous Therapeutics, Inc.
- Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of Shigella flexneri specific oligosaccharides21 Apr 2026US 12,606,587 B2Centre National De La Recherche Scientifique
- Method for synthesizing C-nucleoside compound24 Mar 2026US 12,583,879 B2Academy of Military Medical Sciences
- Selenoglycoside decoys of glycosylation for anti-inflammatory and antiviral pharmaceuticals17 Sep 2026US 2026/0272965 A1
- Pyranoside compounds and methods13 Aug 2026US 2026/0234178 A1
- Nucleic acid ligand and conjugate thereof, and preparation method therefor and use thereof13 Aug 2026US 2026/0234613 A1Tuojie Biotech (Shanghai) Co., Ltd.
- Vaccine against klebsiella pneumoniae28 May 2026US 2026/0144856 A1Idorsia Pharmaceuticals Ltd
- Molecular degraders of extracellular proteins7 May 2026US 2026/0125410 A1
Most cited
By later US patents
- Oligonucleotides with selectably cleavable and/or abasic sites574US 5,367,066 AChiron Corporation · 1994
- Ligands to enhance cellular uptake of biomolecules261US 5,994,517 A1999
- Bis-modified bicyclic nucleic acid analogs253US 7,666,854 B2Isis Pharmaceuticals, Inc. · 2010
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Multifunctional nucleic acid monomer248US 5,545,730 AChiron Corporation · 1996